ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) Long Term Investor Investigation Announced
An investigation on behalf of current long-term stockholders of shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) was announced concerning whether certain ImmunoCellular Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements.
View full press release